Topiramate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 42291-957
  • Package NDC 42291-957-30
  • Application number ANDA206210
  • SPL ID 48c104bb-d8d9-2940-e063-6394a90aeab3
  • SPL set ID 25b377f7-ea89-fb56-e063-6394a90a239d
  • UNII 0H73WJJ391
  • RxCUI 1436239
  • RxCUI 1437278
  • RxCUI 1437283
  • RxCUI 1437288

What the source publishes

Labeler
AvKARE
Active ingredients
Topiramate
Form
CAPSULE, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:42291-957_48c104bb-d8d9-2940-e063-6394a90aeab3
{
  "name": "Topiramate",
  "splId": "48c104bb-d8d9-2940-e063-6394a90aeab3",
  "labels": [
    {
      "setId": "25b377f7-ea89-fb56-e063-6394a90a239d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25b377f7-ea89-fb56-e063-6394a90a239d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=25b377f7-ea89-fb56-e063-6394a90a239d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AvKARE",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-957-30)",
      "package_ndc": "42291-957-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20241030"
    }
  ],
  "productId": "42291-957_48c104bb-d8d9-2940-e063-6394a90aeab3",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE, EXTENDED RELEASE",
  "productNdc": "42291-957",
  "deaSchedule": null,
  "genericName": "Topiramate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOPIRAMATE",
      "strength": "100 mg/1"
    }
  ],
  "applicationNumber": "ANDA206210",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20241030",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486",
      "N0000185506",
      "N0000182140"
    ],
    "upc": [
      "0342291958302",
      "0342291957305",
      "0342291956308"
    ],
    "unii": [
      "0H73WJJ391"
    ],
    "rxcui": [
      "1436239",
      "1437278",
      "1437283",
      "1437288"
    ],
    "spl_set_id": [
      "25b377f7-ea89-fb56-e063-6394a90a239d"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 3A4 Inducers [MoA]",
      "Cytochrome P450 2C19 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "AvKARE"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:42291-957_48c104bb-d8d9-2940-e063-6394a90aeab3"